chr16-51141732-T-TGCCGCC
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP3BS1_SupportingBS2
The NM_002968.3(SALL1):c.484_489dupGGCGGC(p.Gly162_Gly163dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,610,726 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002968.3 conservative_inframe_insertion
Scores
Clinical Significance
Conservation
Publications
- Townes-Brocks syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Townes-Brocks syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002968.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SALL1 | NM_002968.3 | MANE Select | c.484_489dupGGCGGC | p.Gly162_Gly163dup | conservative_inframe_insertion | Exon 2 of 3 | NP_002959.2 | ||
| SALL1 | NM_001127892.2 | c.193_198dupGGCGGC | p.Gly65_Gly66dup | conservative_inframe_insertion | Exon 2 of 3 | NP_001121364.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SALL1 | ENST00000251020.9 | TSL:1 MANE Select | c.484_489dupGGCGGC | p.Gly162_Gly163dup | conservative_inframe_insertion | Exon 2 of 3 | ENSP00000251020.4 | ||
| SALL1 | ENST00000566102.1 | TSL:1 | c.77-4186_77-4181dupGGCGGC | intron | N/A | ENSP00000455582.1 | |||
| SALL1 | ENST00000440970.6 | TSL:5 | c.484_489dupGGCGGC | p.Gly162_Gly163dup | conservative_inframe_insertion | Exon 3 of 4 | ENSP00000407914.2 |
Frequencies
GnomAD3 genomes AF: 0.000199 AC: 30AN: 150846Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000603 AC: 15AN: 248582 AF XY: 0.0000668 show subpopulations
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1459762Hom.: 0 Cov.: 53 AF XY: 0.0000248 AC XY: 18AN XY: 726184 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.000199 AC: 30AN: 150964Hom.: 0 Cov.: 32 AF XY: 0.000230 AC XY: 17AN XY: 73810 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Townes syndrome Uncertain:1
This variant, c.484_489dup, results in the insertion of 2 amino acid(s) of the SALL1 protein (p.Gly162_Gly163dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs779674923, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SALL1-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
SALL1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at